Showing 8831-8840 of 20877 results for "".
Enhancing Lupus Nephritis Outcomes: The Potential Impact of Lower Glucocorticoid Doses
https://reachmd.com/programs/living-rheum/enhancing-lupus-nephritis-outcomes-the-potential-impact-of-lower-glucocorticoid-doses/30075/Read about recent findings on the efficacy and safety of low-dose glucocorticoids in patients with lupus nephritis.Current & Emerging Therapies: Treating & Preventing Hereditary Angioedema Attacks in Children & Adults
https://reachmd.com/programs/cme/current-emerging-therapies-treating-preventing-hereditary-angioedema-attacks-in-children-adults/37604/Provided by RMEI Medical Education, LLC. Supported by independent educational grants from Intellia Therapeutics, Pharming Healthcare, Inc., and Pharvaris.GA Case Compendium: Identification of Geographic Atrophy on Color Fundus Photography
https://reachmd.com/resources/geographic-atrophy-case-compendium/ga-case-compendium-identification-of-geographic-atrophy-on-color-fundus-photography/56702/The Regulatory Environment for the Artificial Pancreas
https://reachmd.com/programs/diabetes-discourse/the-regulatory-environment-for-the-artificial-pancreas/6500/The artificial pancreas project lead by the Juvenile Diabetes Research Foundation has made tremendous progress towards eventual outpatient clinical studies. A recent panel of experts met with the FDA and NIH to determine appropriate guidelines. What are regulatory guidelines for the artificial panMS Minute: Disparities in Multiple Sclerosis: Incorporating Equity Into Clinical Care and Research
https://reachmd.com/diseases-diagnoses/ms-immune-disorders/ms-minute-disparities-in-multiple-sclerosis-incorporating-equity-into-clinical-care-and-research/32018/Assessing biologic, genetic, and social factors of patients with MS to shrink the gap in care for underrepresented populations.Oral Contraceptives and Endometrial Cancer: Examining a Potential Dose-Response Protective Effect
https://reachmd.com/programs/project-oncology/oral-contraceptives-and-endometrial-cancer-examining-a-potential-dose-response-protective-effect/35506/As rates of endometrial cancer rise globally, a 2025 meta-analysis offers compelling evidence that oral contraceptives (OCs) could significantly reduce EMC risk. Explore the findings from this new review and its potential implications for the future of patient care.Ibrutinib-Venetoclax in Relapsed CLL: MRD-Guided Approach Balances Efficacy and Safety
https://reachmd.com/programs/project-oncology/ibrutinib-venetoclax-in-relapsed-cll-mrd-guided-approach-balances-efficacy-and-safety/37206/Measuring IgAN Risk: Genetic, Environmental, and Systemic Factors
https://reachmd.com/programs/clinicians-roundtable/measuring-igan-risk-genetic-environmental-and-systemic-factors/29742/Learn about common risk factors for IgA nephropathy.Deciphering IgA Nephropathy: Insights into the Diagnostic Process
https://reachmd.com/programs/frontlines-iga-nephropathy/deciphering-iga-nephropathy-insights-into-the-diagnostic-process/26946/When IgA nephropathy is suspected, it’s important to follow a stepwise pattern to confirm those suspicions. Here’s what the diagnostic process looks like.Applying the 2024 McDonald Criteria: Real-World Impacts on MS Diagnosis
https://reachmd.com/programs/neurofrontiers/mcdonald-criteria-impacts-ms-diagnosis/56634/Early real-world experience with the 2024 McDonald criteria suggests a meaningful increase in multiple sclerosis (MS) diagnoses, driven largely by recognition of optic nerve involvement and reclassification of radiologically isolated syndrome. Hear from Dr. Aaron Miller as he reviews emerging